Armata Pharmaceuticals Inc (ARMP)
2.59
-0.06
(-2.26%)
USD |
NYAM |
May 17, 16:00
2.64
+0.05
(+1.93%)
Pre-Market: 20:00
Armata Pharmaceuticals 1 Year Total Returns (Daily): 107.2% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | 107.2% |
May 16, 2024 | 90.65% |
May 15, 2024 | 94.85% |
May 14, 2024 | 133.6% |
May 13, 2024 | 156.8% |
May 10, 2024 | 129.0% |
May 09, 2024 | 154.7% |
May 08, 2024 | 106.0% |
May 07, 2024 | 93.24% |
May 06, 2024 | 69.59% |
May 03, 2024 | 61.69% |
May 02, 2024 | 65.23% |
May 01, 2024 | 54.84% |
April 30, 2024 | 57.41% |
April 29, 2024 | 60.49% |
April 26, 2024 | 78.06% |
April 25, 2024 | 54.32% |
April 24, 2024 | 55.28% |
April 23, 2024 | 52.44% |
April 22, 2024 | 51.23% |
April 19, 2024 | 64.61% |
April 18, 2024 | 63.46% |
April 17, 2024 | 51.52% |
April 16, 2024 | 98.76% |
April 15, 2024 | 100.6% |
Date | Value |
---|---|
April 12, 2024 | 127.3% |
April 11, 2024 | 123.6% |
April 10, 2024 | 115.2% |
April 09, 2024 | 128.5% |
April 08, 2024 | 128.5% |
April 05, 2024 | 150.3% |
April 04, 2024 | 141.6% |
April 03, 2024 | 114.7% |
April 02, 2024 | 119.2% |
April 01, 2024 | 133.5% |
March 28, 2024 | 169.7% |
March 27, 2024 | 156.2% |
March 26, 2024 | 176.7% |
March 25, 2024 | 167.8% |
March 22, 2024 | 126.7% |
March 21, 2024 | 129.2% |
March 20, 2024 | 102.3% |
March 19, 2024 | 98.95% |
March 18, 2024 | 81.05% |
March 15, 2024 | 116.9% |
March 14, 2024 | 96.51% |
March 13, 2024 | 83.51% |
March 12, 2024 | 85.28% |
March 11, 2024 | 71.57% |
March 08, 2024 | 61.36% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.16%
Minimum
Jun 10 2019
240.4%
Maximum
Dec 28 2023
-4.09%
Average
-2.45%
Median
Jan 04 2021
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -19.40% |
Perspective Therapeutics Inc | 252.7% |
Protalix BioTherapeutics Inc | -51.69% |
Electromed Inc | 32.31% |
Xtant Medical Holdings Inc | 14.30% |